Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Kian Santang Muliatama Tbk. (RGAS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Kian Santang Muliatama Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Kian Santang Muliatama Tbk. trades at Rp114 (market cap 163.43B, 36.43M 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. and Kian Santang Muliatama Tbk. are close in size by market cap, and Kian Santang Muliatama Tbk. is more actively traded (36.43M versus 324K). Which is the better fit depends on your goals.
| OBAT | RGAS | |
|---|---|---|
Market Cap | 166.01B | 163.43B |
Volume | 324K | 36.43M |
Lot | 3.24K | 364.26K |
Turnover | 77.68M | 4B |
Average Price | 239.75 | 109.89 |
Value | 77.68M | 4B |
Indicative Equilibrium Price | 240 | 114 |
Indicative Equilibrium Volume | 1 | 5.9K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Kian Santang Muliatama Tbk.
PT Kian Santang Muliatama Tbk (the Entity) was established based on the Notarial Deed of Artisa Khamelia Ramadiyanti, S.H., M.Kn., No. 634, dated November 28, 2018. The Entity started its commercial operations on 2019. The controlling party for the Company is Edy Nurhamid Amin.
Read more on RGAS →
